Results 71 to 80 of about 56,167 (240)

The Dual Immunoregulatory Role of CREB3L1 Underlying Latent and Severe Tuberculosis Clinical Manifestation

Immunology, EarlyView.
RNA‐seq of lungs and livers from Mycobacterium tuberculosis‐infected mice with distinct disease outcomes revealed organ‐specific responses driven by differences in immune activity and bacterial burden. Meta‐analysis identified orthologous genes shared with human latent TB and mouse liver, with Creb3l1, Myo7b, Cyyr1 and Cbs differentially expressed and ...
Felipe T. Lima, Ricardo C. Castro, Francisco R. Javier, Caroline Fontanari, Valdes R. Bollela, Rogerio S. Rosada, Célio L. Silva, Lúcia H. Faccioli, Luiz G. Gardinassi, Fabiani G. Frantz   +9 more
wiley   +1 more source

Study of the possibility of improving the differentiation of latent and active tuberculosis infection

Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, 2019
Latent TB infection (LTI)-asymptomatic nontransmissiv tuberculosis infection with hidden persistence of M.tuberculosis in host organism. The problem of detection of latent tuberculosis infection is very urgent and difficult task.
Zyifi Kadimova
doaj  

Tuberculosis contact tracing among children and adolescent referred to children's hospital in Rio de Janeiro, Brazil

Brazilian Journal of Infectious Diseases, 2015
Objective: To describe the investigation of latent tuberculosis infection and indication for isoniazid preventive therapy in children and adolescents evaluated at the children's hospital. Methods: This retrospective study examines all latent tuberculosis
Angela Marcia Cabral Mendonça, Afrânio Lineu Kritski, Clemax Couto Sant’Anna   +2 more
doaj   +1 more source

Latent Multi-drug Resistant Tuberculosis: An Unaddressed Problem [PDF]

, 2020
Gyanshankar Mishra, Jasmin Mulani
openalex   +1 more source

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

Journal of the European Academy of Dermatology and Venereology, EarlyView.
New 2025 French guidelines update psoriasis management with revised algorithms integrating recent systemic therapies. They recommend methotrexate, adalimumab or ustekinumab as first‐line treatments and provide guidance for special psoriasis forms, comorbidities, pregnancy and long‐term management.
Marie Masson Regnault, Emilie Brenaut, Marie‐Emeline Marniquet, Carla Berthault, Lea Canoen, Clarisse Marcombes, Audrey Melin, Raphaël Ouakrat, Julie Charles, Stephane Mouret, Olivier Potie, Laetitia Penso, Laura Pina Vegas, Guillaume Larid, Marine Roux, Colombe Bougeard, Sandy Sylvain, Clara Labonne, Tania Randriamiarana, Da Hee Pitaud, Floriane Etheve, Jeremy Gottlieb, Laurie Gouillon, Marine Chastagner, Emilie Sbidian, Hélène Aubert, on behalf of the Psoriasis Research Group of the French Society of Dermatology (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie), Hélène Aubert, Marie Masson Regnault, Emilie Brenaut, Emilie Sbidian, Laura Pina Vegas, Laetitia Penso, Jeremy Gottlieb, Marine Roux, Clara Labonne, Tania Randriamiarana, Floriane Etheve, Da Hee Pitaud, Marie‐Emeline Marniquet, Carla Berthault, Clarisse Marcombes, Audrey Melin, Colombe Bougeard, Julie Charles, Olivier Potie, Léa Canoen, Laurie Gouillon, Marine Chastagner, Sandy Sylvain, Guillaume Larid, Raphaël Ouakrat   +51 more
wiley   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui, Marnie Bertolet, Daniel E. Forman, Michelle E. Danielson, Shanshan Yao, Oscar L. Lopez, Nancy W. Glynn, Neelesh K. Nadkarni, Akira Sekikawa, Tullia C. Bruno, Toren Finkel, Anne B. Newman   +11 more
wiley   +1 more source

Frequency of Latent Tuberculosis Infection in Patients with Type 2 Diabetes referred to Shahid Rahimi Hospital in Khorramabad City with Tuberculin Skin Test in 2018-2020

Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2022
Introduction: Tuberculosis is the leading cause of death from infectious diseases worldwide. Diabetes has been suggested as an important risk factor for tuberculosis.
Mahshad Mousavi, Nazanin Mousavi, Majid Abdollahian, Mozhgan Kaviani   +3 more
doaj  

Excessive Daytime Sleepiness, but Not Insomnia Is Associated With Dyslipidaemia in Patients With Obstructive Sleep Apnoea Participating in ESADA

Journal of Sleep Research, EarlyView.
ABSTRACT Excessive daytime sleepiness (EDS) as well as insomnia have been associated with a higher risk for cardiovascular disease in patients with obstructive sleep apnoea (OSA). The link is not fully understood but may involve dyslipidaemia. The aim of the study was to analyse if the EDS and insomnia phenotypes were associated with deranged serum ...
Andras Bikov, Sebastien Bailly, Ulla Anttalainen, Tarja Saaresranta, Ozen K. Basoglu, Sophia Schiza, Izolde Bouloukaki, Pawel Sliwinski, Athanasia Pataka, Dries Testelmans, Francesco Fanfulla, Haralampos Gouveris, Ludger Grote, Stefan Mihaicuta, the ESADA collaborators, P. Steiropoulos, J. Verbraecken, E. Petiet, Georgia Trakada, I. Fietze, T. Penzel, Ondrej Ludka, I. Bouloukaki, S. Schiza, W. T. McNicholas, S. Ryan, R. L. Riha, J. A. Kvamme, L. Grote, J. Hedner, D. Zou, Katrien Hertegonne, Dirk Pevernagie, S. Bailly, J. L. Pépin, R. Tamisier, H. Hein, O. K. Basoglu, M. S. Tasbakan, P. Joppa, R. Staats, Dries Testelmans, Alexandros Kalkanis, Haralampos Gouveris, K. Ludwig, C. Lombardi, G. Parati, M. R. Bonsignore, Francesco Fanfulla, M. Petitjean, G. Roisman, M. Drummond, M. van Zeller, W. Randerath, S. Mathes, Z. Dogas, T. Galic, A. Pataka, S. Mihaicuta, U. Anttalainen, T. Saaresranta, P. Sliwinski   +61 more
wiley   +1 more source

Identification of ferroptosis-related gene signature for tuberculosis diagnosis and therapy efficacy

iScience
Summary: Diagnosis of tuberculosis remains a challenge when microbiological tests are negative. Immune cell atlas of patients with tuberculosis and healthy controls were established by single-cell transcriptome.
Bingfen Yang, Fei Zhai, Zhimin Li, Xinjing Wang, Xianping Deng, Zhihong Cao, Yanhua Liu, Ruo Wang, Jing Jiang, Xiaoxing Cheng   +9 more
doaj   +1 more source

Comparison of Rifampin and Isoniazid for Latent Tuberculosis Infection in Kidney Transplant Candidates: Focus on Tolerability and Treatment Completion

Transplant Infectious Disease, EarlyView.
This study comparing 4‐month rifampin with 9‐month isoniazid for latent tuberculosis in kidney transplant candidates showed higher treatment completion rates and no transaminase elevations in the rifampin group. However, some patients experienced an increase in blood pressure while taking antihypertensive medications known to interact with rifampin ...
Jacques Simkins, Julia Bini Viotti, Yoichiro Natori, Shweta Anjan, Adela Mattiazzi, Mariella Ortigosa‐Goggins, Giselle Guerra, David Roth, Warren Kupin, Javier A. Pagan, Franco Cabeza, Gaetano Ciancio, Mahmoud Morsi, Michele I. Morris   +13 more
wiley   +1 more source